Bibliographic Details
| Title: |
Neuroprotective effects of Shende'an tablet in the Parkinson's disease model. |
| Authors: |
Sheng, Xiaoyan1 (AUTHOR), Yang, Shuiyuan2 (AUTHOR), Wen, Xiaomin3 (AUTHOR), Zhang, Xin4 (AUTHOR), Ye, Yongfeng5 (AUTHOR), Zhao, Peng3 (AUTHOR), Zang, Limin6 (AUTHOR), Peng, Kang3 (AUTHOR) ksd973@163.com, Du, Enming7 (AUTHOR) dem-3882608@163.com, Li, Sai4 (AUTHOR) lisai0716@163.com |
| Source: |
Chinese Medicine. 2/6/2021, Vol. 16 Issue 1, p1-11. 11p. |
| Subject Terms: |
*DRUG therapy for Parkinson's disease, *ANIMAL experimentation, *APOPTOSIS, *CELL culture, *CELLULAR signal transduction, *DOPAMINE, *FLOW cytometry, *FLUORESCENT antibody technique, *CHINESE medicine, *MICE, *STAINS & staining (Microscopy), *DRUG tablets, *WESTERN immunoblotting, *TREATMENT effectiveness, *NEUROPROTECTIVE agents, *DATA analysis software, *CELL survival, *DESCRIPTIVE statistics, *IN vitro studies, *IN vivo studies, *PHARMACODYNAMICS |
| Abstract: |
Background: Shende'an tablet (SDA) is a newly capsuled Chinese herbal formula derived from the Chinese traditional medicine Zhengan Xifeng Decoction which is approved for the treatment of neurasthenia and insomnia in China. This study aimed to investigate the neuroprotective effects of SDA against Parkinson's disease (PD) in vitro and in vivo. Methods: In the present work, the neuroprotective effects and mechanism of SDA were evaluated in the cellular PD model. Male C57BL/6J mice were subject to a partial MPTP lesion alongside treatment with SDA. Behavioural test and tyrosine-hydroxylase immunohistochemistry were used to evaluate nigrostriatal tract integrity. HPLC analysis and Western blotting were used to assess the effect of SDA on dopamine metabolism and the expression of HO-1, PGC-1α and Nrf2, respectively. Results: Our results demonstrated that SDA had neuroprotective effect in dopaminergic PC12 cells with 6-OHDA lesion. It had also displayed efficient dopaminergic neuronal protection and motor behavior alleviation properties in MPTP-induced PD mice. In the PC12 cells and MPTP-induced Parkinson's disease animal models, SDA was highly efficacious in α-synuclein clearance associated with the activation of PGC-1α/Nrf2 signal pathway. Conclusions: SDA demonstrated potential as a future therapeutic modality in PD through protecting dopamine neurons and alleviating the motor symptoms, mediated by the activation of PGC-1α/Nrf2 signal pathway. [ABSTRACT FROM AUTHOR] |
|
Copyright of Chinese Medicine is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
